Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,630,568
-
Share change
-
+784,628
-
Total reported value
-
$342,850,715
-
Price per share
-
$11.55
-
Number of holders
-
118
-
Value change
-
-$4,522,528
-
Number of buys
-
61
-
Number of sells
-
35
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q3 2020
As of 30 Sep 2020,
G1 THERAPEUTICS INC - COM (GTHX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,630,568 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, MPM ONCOLOGY IMPACT MANAGEMENT LP, GOLDMAN SACHS GROUP INC, and HILLHOUSE CAPITAL ADVISORS, LTD..
This page lists
118
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.